Spliceor Ltd 12826144 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is Research and experimental development on biotechnology Digita Accounts Production Advanced 6.30.9574.0 true 12826144 2024-09-01 2025-08-31 12826144 2025-08-31 12826144 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-08-31 12826144 core:CurrentFinancialInstruments 2025-08-31 12826144 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 12826144 core:Non-currentFinancialInstruments core:AfterOneYear 2025-08-31 12826144 core:OfficeEquipment 2025-08-31 12826144 core:PlantMachinery 2025-08-31 12826144 bus:SmallEntities 2024-09-01 2025-08-31 12826144 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 12826144 bus:FilletedAccounts 2024-09-01 2025-08-31 12826144 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12826144 bus:RegisteredOffice 2024-09-01 2025-08-31 12826144 bus:Director1 2024-09-01 2025-08-31 12826144 bus:Director2 2024-09-01 2025-08-31 12826144 bus:Director3 2024-09-01 2025-08-31 12826144 bus:Director4 2024-09-01 2025-08-31 12826144 bus:Director5 2024-09-01 2025-08-31 12826144 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-09-01 2025-08-31 12826144 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12826144 core:PatentsTrademarksLicencesConcessionsSimilar 2024-09-01 2025-08-31 12826144 core:OfficeEquipment 2024-09-01 2025-08-31 12826144 core:PlantMachinery 2024-09-01 2025-08-31 12826144 countries:EnglandWales 2024-09-01 2025-08-31 12826144 2024-08-31 12826144 core:OfficeEquipment 2024-08-31 12826144 core:PlantMachinery 2024-08-31 12826144 2023-09-01 2024-08-31 12826144 2024-08-31 12826144 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-08-31 12826144 core:CurrentFinancialInstruments 2024-08-31 12826144 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 12826144 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 12826144 core:OfficeEquipment 2024-08-31 12826144 core:PlantMachinery 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12826144

Spliceor Ltd
Unaudited Filleted Abridged Financial Statements
for the Year Ended 31 August 2025

Spliceor Ltd

Contents

Company Information | 1
Abridged Balance Sheet | 2 to 3
Notes to the Unaudited Abridged Financial Statements | 4 to 9

Spliceor Ltd

Company Information

Directors | Dr C Ingemarsdotter Dr M Treherne Dr T Landy Dr S Goldsmith A Foxley

Registered office | Meditrina building (B260) Babraham Research Campus Brabraham Cambridge CB22 3AT

Spliceor Ltd

(Registration number: 12826144)
Abridged Balance Sheet as at 31 August 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | 45,488 | 31,966
Tangible assets | 5 | 3,529 | 108
|  | 49,017 | 32,074
Current assets |  |  |
Debtors |  | 37,848 | 18,687
Cash at bank and in hand |  | 397,341 | 10,424
|  | 435,189 | 29,111
Creditors: Amounts falling due within one year |  | (18,247) | (12,802)
Net current assets |  | 416,942 | 16,309
Total assets less current liabilities |  | 465,959 | 48,383
Creditors: Amounts falling due after more than one year |  | (1,074,692) | (500,000)
Net liabilities |  | (608,733) | (451,617)
Capital and reserves |  |  |
Called up share capital | 6 | 1 | 1
Retained earnings |  | (608,734) | (451,618)
Shareholders' deficit |  | (608,733) | (451,617)

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 15 May 2026 and signed on its behalf by:

Spliceor Ltd

(Registration number: 12826144)
Abridged Balance Sheet as at 31 August 2025 (continued)

......................................... Dr M Treherne Director

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Meditrina building (B260)
Babraham Research Campus
Brabraham
Cambridge
CB22 3AT
United Kingdom

These financial statements were authorised for issue by the Board on 15 May 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025 (continued)

2 | Accounting policies (continued)

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office Equipment | 33% Straight Line

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.
Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.
Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025 (continued)

2 | Accounting policies (continued)

Asset class | Amortisation method and rate
Intangible Assets | 25% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025 (continued)

2 | Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

4 | Intangible assets

| Total £
Cost or valuation
At 1 September 2024 | 31,966
Additions acquired separately | 13,522
At 31 August 2025 | 45,488
Amortisation
Carrying amount
At 31 August 2025 | 45,488
At 31 August 2024 | 31,966

The aggregate amount of research and development expenditure recognised as an expense during the period is £8,949 (2024 - £50,499).

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025 (continued)

5 | Tangible assets

| Plant and machinery £ | Office equipment £ | Total £
Cost or valuation
At 1 September 2024 | - | 1,949 | 1,949
Additions | 3,850 | - | 3,850
At 31 August 2025 | 3,850 | 1,949 | 5,799
Depreciation
At 1 September 2024 | - | 1,841 | 1,841
Charge for the year | 321 | 108 | 429
At 31 August 2025 | 321 | 1,949 | 2,270
Carrying amount
At 31 August 2025 | 3,529 | - | 3,529
At 31 August 2024 | - | 108 | 108

6 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary Shares of £0.00 each | 1,241,379 | 1 | 1,241,379 | 1

7 | Related party transactions

Spliceor Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025 (continued)

7 | Related party transactions (continued)

Directors' remuneration

The directors' remuneration for the year was as follows:

| 2025 £ | 2024 £
Remuneration | 91,827 | 42,000
Contributions paid to money purchase schemes | 2,755 | 1,200
| 94,582 | 43,200